Coronary artery bypass in patients 80 years and older: comparison with a younger age group

Hiroyuki Tanaka1, Takashi Narisawa, Mikio Masuda

  • 1Department of Thoracic Cardiovascular Surgery, Showa University Fujigaoka Hospital, Yokohama, Japan.

Insights

Octogenarians undergoing coronary artery bypass grafting (CABG) experienced acceptable outcomes. Off-pump CABG in elderly patients showed reduced mortality and morbidity compared to younger groups.

Area of Science:

  • Cardiovascular Surgery
  • Geriatric Medicine
  • Anesthesiology

Background:

  • Elderly patients (≥80 years) face higher risks for complications after coronary artery bypass grafting (CABG).
  • Comparing outcomes in octogenarians versus younger elderly patients is crucial for surgical decision-making.

Purpose of the Study:

  • To compare perioperative outcomes of coronary artery bypass grafting (CABG) in octogenarians versus patients aged 70-79 years.
  • To evaluate the safety and efficacy of off-pump CABG in octogenarian patients.

Main Methods:

  • Retrospective comparison of perioperative outcomes for CABG patients aged ≥80 years (n=15) and 70-79 years (n=64) from March 1997 to June 2003.
  • Analysis included comorbidities, surgical approach (on-pump vs. off-pump), revascularization completeness, and postoperative complications.

Main Results:

  • Octogenarians had higher rates of congestive heart failure (40% vs. 9%) and underwent off-pump CABG more frequently (80% vs. 42%).
  • No significant differences in emergent surgery or graft numbers were observed.
  • Octogenarians experienced more minor wound complications (20% vs. 3%) but had no operative deaths, unlike the younger group (6% mortality).

Conclusions:

  • Off-pump CABG can be performed in octogenarians with acceptable perioperative mortality and morbidity.
  • Surgical myocardial revascularization is feasible in octogenarians, with careful consideration of comorbidities and surgical technique.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...